The combination of zanzalintinib plus nivolumab demonstrated encouraging preliminary activity with manageable safety.
Jad Chahoud, MD, MPH, MHA
Advertisement
Jad Chahoud, MD, MPH, MHA, is a genitourinary medical oncologist at Moffitt Cancer Center in Tampa, Florida.
Articles by Jad Chahoud, MD, MPH, MHA
Jad Chahoud, MD, MPH, MHA, discusses the mechanism of action for zanzalintinib and walks through key design elements of the STELLAR-002 trial.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
